| Cellular and Molecular Biology 1: Expression Profiling and Analysis of Cancer Biology |
| Cellular and Molecular Biology 6: Molecular Genetics 1 |
| Cellular and Molecular Biology 2: Informatics in Genetic and Expression Analysis |
| Cellular and molecular biology 2: Informatics in Genetic and Expression Analysis |
| Chemistry 2: Proteomic Analysis: Methods and Applications |
| Cellular and Molecular Biology 3: Mechanisms of Transcriptional Control |
| Cellular and Molecular Biology 4: Microarrays and Cancer Profiling |
| Cellular and Molecular Biology 5: Molecular Classification of Tumors 1 |
| Cellular and Molecular biology 6: Molecular Genetics 1 |
| Cellular and Molecular Biology 7: Signaling in Head and Neck and Lung Cancers |
| Cellular and Molecular Biology 8: Signaling in Women[apos ]s Cancer / Melanoma and Skin Cancer |
| Tumor Biology 1: Gene Expression Profiling |
| Tumor Biology 2: Mechanisms of Invasion and Motility 1 |
| Tumor Biology 3: Novel Therapies for Tumor Progression and Metastasis |
| Tumor Biology 4: Signaling Pathways in Tumor Progression |
| Tumor Biology 5: Tumor and Metastasis Suppressors and Mechanisms |
| Carcinogenesis 1: Viral Carcinogenesis |
| Chemistry 1: Carcinogen Metabolism and DNA Damage |
| Clinical Research 1: Advances in Technology: Tumor Cell Isolation, Detection, and Clinical Outcome |
| Clinical Research 2: Novel Therapeutics and Biomarkers of Response |
| Epidemiology 1: Determinants of Recurrence, Survival, and Response to Treatment |
| Epidemiology 2: Drug Use and Viral Exposures |
| Experimental and Molecular Therapeutics 1: ABC Transporter Mechanisms of Resistance and Reversal |
| Experimental and Molecular Therapeutics 2: Antibodies in Cancer Therapy |
| Experimental and Molecular Therapeutics 3: Antisense Strategies in Cancer Therapy |
| Experimental and Molecular Therapeutics 4: DNA, Histone, and Proteasome Modulation |
| Experimental and Molecular Therapeutics 5: Novel Agents 1 |
| Experimental and Molecular Therapeutics 6: Targeting Signaling Pathways 1 |
| Immunology 1: Antibody Therapy |
| Immunology 2: Immunotherapy 1 |
| Prevention Research 1: Modulation of Arachidonic Acid Metabolism |
| Prevention Research 2: Molecular Markers in Prevention Research |
| Cellular and Molecular Biology 9: Apoptosis 1: Survival Factors |
| Cellular and Molecular Biology 10: Apoptosis Regulators 1 |
| Cellular and Molecular Biology 11: Methylation Profiling |
| Cellular and Molecular Biology 12: Molecular Classification of Tumors 2 |
| Cellular and Molecular Biology 13: Novel Targets of Epigenetic Silencing in Cancer |
| Cellular and Molecular Biology 14: Receptor Signaling |
| Cellular and Molecular Biology 15: Signaling and Prostate Cancer |
| Cellular and Molecular Biology 16: Signaling Effectors |
| Cellular and Molecular Biology 17: Signaling in Prostate and Other Urogenital Cancers |
| Tumor Biology 6: Animal Models 1 |
| Tumor Biology 7: Animal Models 2: Breast and Female Reproductive Tract |
| Tumor Biology 8: Animal Models 3: Cell Signaling and Cell Cycle |
| Tumor Biology 9: Hypoxia and Tumor Microenvironment |
| Tumor Biology 10: Microvascular Biology |
| Carcinogenesis 2: Chemical Carcinogenesis |
| Chemistry 3: Small Molecule Structure-Activity Relationships |
| Clinical Research 3: Modification of Radiation Sensitivity |
| Clinical Research 4: Molecular Markers in Diagnosis and Prognosis 1: Gastrointestinal Malignancies (Colorectal, Gastric, Pancreatic, and Hepatocellular) |
| Endocrinology 1: Breast Cancer: Hormone Resistance/Signaling |
| Epidemiology 3: Familial and Hereditary Cancer Risk |
| Experimental and Molecular Therapeutics 7: Adenoviral Vectors for Gene Therapy of Cancer |
| Experimental and Molecular Therapeutics 8: DNA Reactive Agents / Alkylating Agents |
| Experimental and Molecular Therapeutics 9: Drug Delivery |
| Experimental and Molecular Therapeutics 10: Drug Targeting |
| Experimental and Molecular Therapeutics 11: Experimental Radiotherapy |
| Experimental and Molecular Therapeutics 12: Mechanisms of Resistance and Sensitivity to Platinum-based Compounds |
| Experimental and Molecular Therapeutics 13: Protein Kinases / Phosphatases and Other Targets for Therapy |
| Experimental and Molecular Therapeutics 21: Identification of Molecular Targets 2 |
| Immunology 3: Immune Diagnosis and Monitoring |
| Prevention Research 3: Biological and Biochemical Mechanisms in Prevention 1 |
| Prevention Research 4: Biomarkers and Clinical Prevention Studies |
| Cellular and Molecular Biology 18: DNA Repair and Genomic Instability |
| Cellular and Molecular Biology 19: Informatics Integration in Cancer Research |
| Cellular and Molecular Biology 20: Translational Genomics of Human Reproductive and Urologic Tumors |
| Tumor Biology 11: Radiation Biology 1 |
| Clinical Research 5: Molecular Correlates of Response and Survival |
| Experimental and Molecular Therapeutics 14: Cellular Responses to Cancer Therapeutics |
| Experimental and Molecular Therapeutics 15: Modulation of Antiapoptotic Pathways |
| Experimental and Molecular Therapeutics 16: RNAi Application to Drug Discovery and Protein-Protein Inhibitors |
| Cellular and Molecular Biology 21: Apoptosis 2: Chemotherapeutic Agents I |
| Cellular and Molecular Biology 22: Apoptosis 3: Death Receptors I |
| Cellular and Molecular Biology 23: DNA Damage and Repair 1 |
| Cellular and Molecular Biology 24: Epigenetic Therapy |
| Cellular and Molecular Biology 25: Gene Methylation in Cancer |
| Cellular and Molecular Biology 26: Gene Regulation and Transcription Factors |
| Cellular and Molecular Biology 27: Molecular Genetics 2: Breast Cancer |
| Cellular and Molecular Biology 28: Molecular Genetics 3: Gastrointestinal Cancers |
| Cellular and Molecular Biology 29: Transcriptional and Post-Transcriptional Control |
| Tumor Biology 12: Animal Models 4: Genitourinary and Gastrointestinal |
| Tumor Biology 13: Radiation Biology 2 |
| Tumor Biology 14: Signaling and Angiogenesis |
| Tumor Biology 15: Stem Cell Biology 1 |
| Tumor Biology 16: Stem Cell Biology 2 |
| Carcinogenesis 3: Environmental and Hormonal Carcinogenesis |
| Chemistry 4: Chemical Aspects of Carcinogenesis: DNA Adducts and Damage |
| Clinical Research 6: Endocrine Cancers: Hormone Receptors, Gene Expression, and Prognosis |
| Clinical Research 7: Molecular Markers of Response |
| Epidemiology 4: Biomarkers of Human Exposure to Carcinogens and DNA Damaging Agents |
| Epidemiology 5: Biomarkers of Human Exposure to Tobacco |
| Experimental and Molecular Therapeutics 17: Apoptosis: Therapeutic Applications |
| Experimental and Molecular Therapeutics 18: Cell Cycle Mechanisms of Anticancer Drug Action |
| Experimental and Molecular Therapeutics 19: Cell Signaling Responses to Anticancer Agents |
| Experimental and Molecular Therapeutics 19: Cell Signaling Responses ti Anticancer Agents |
| Experimental and Molecular Therapeutics 20: Identification of Molecular Targets 1 |
| Experimental and Molecular Therapeutics 22: Identifying New Targets |
| Experimental and Molecular Therapeutics 23: Targeting Topoisomerases |
| Immunology 4: Cellular Mechanisms of Regulation of Tumor Immunity |
| Prevention Research 5: Biological and Biochemical Mechanisms in Prevention 2 |
| Prevention Research 6: Prevention of Aerodigestive Cancers |
| Cellular and Molecular Biology 30: Cell Death |
| Cellular and Molecular Biology 31: Tumor Suppressor Pathways |
| Tumor Biology 17: Novel Models and Therapeutic Approaches |
| Chemistry 5: Chemical Approaches to Novel Anticancer Agents |
| Clinical Research 8: Cancer and Aging: Genes to Outcomes |
| Clinical Research 9: Genetic Modulation in Unique Populations |
| Epidemiology 6: Genetic Variation in Pathways in Cancer |
| Experimental and Molecular Therapeutics 24: Novel Therapeutic Targets |
| Cellular and Molecular Biology 33: Signaling Pathways in Cancer |
| Tumor Biology 18: Inflammation, Microenvironment, and Tumor Progression |
| Carcinogenesis 4: Skin Carcinogenesis in Murine Models |
| Clinical Research 10: Molecular Profiling: Diagnosis, Prognosis, and New Targets |
| Experimental and Molecular Therapeutics 25: Mechanisms of Drug Resistance and Reversal |
| Immunology 5: Regulatory and Effector T Cells in Tumor Immunity |
| Prevention Research 7: Mechanisms of Action of Chemoprevention Agents |
| Cellular and Molecular Biology 34: Apoptosis Regulators 2 |
| Cellular and Molecular Biology 35: Cancer Profiling and Therapeutics |
| Cellular and Molecular Biology 36: Epigenetic Mechanisms 1 |
| Cellular and Molecular Biology 37: Epigenetics: Clinical Implications |
| Cellular and Molecular Biology 38: Oncogenic Pathways in Cancer |
| Cellular and Molecular Biology 39: Senescence |
| Cellular and Molecular Biology 40: Tumor Suppressors 1 |
| Cellular and Molecular Biology 41: Tumor Suppressors 2 |
| Tumor Biology 19: Metastasis to Bone |
| Tumor Biology 20: Pediatric Cancer 1: Neuroblastoma |
| Tumor Biology 21: Proteolytic Systems |
| Tumor Biology 22: Translational Angiogenesis 1 |
| Tumor Biology 23: Translational Angiogenesis 2 |
| Carcinogenesis 5: Mutagenesis and DNA Damage and Repair |
| Chemistry 6: Natural Products |
| Chemistry 7: Proteomic Analysis and Tumor Cell Biology |
| Clinical Research 11: Molecular Markers in Diagnosis and Prognosis 2: Breast Cancer |
| Clinical Research 12: Molecular Markers in Diagnosis and Prognosis 3: Urologic Cancers |
| Endocrinology 2: Prostate: Inhibitors, Receptors, Gene Expression, and Signaling Pathways |
| Epidemiology 7: Hormone-related Cancers |
| Epidemiology 8: Polymorphisms Related to Hormone Metabolism, Growth Factors, and Cell Cycle Control |
| Experimental and Molecular Therapeutics 26: Actions on Gene Expression |
| Experimental and Molecular Therapeutics 27: Antimicrotubule and Antimetabolite Resistance Mechanisms |
| Experimental and Molecular Therapeutics 28: Cell Death Pathways |
| Experimental and Molecular Therapeutics 29: Nonviral Gene Therapy Approaches to Cancer |
| Experimental and Molecular Therapeutics 30: Novel Approaches for Gene Therapy of Cancer |
| Experimental and Molecular Therapeutics 31: Targeting Epidermal Growth Factor Receptors |
| Experimental and Molecular Therapeutics 32: Targeting Microtubules |
| Immunology 6: Tumor Vaccines 1 |
| Prevention Research 8: Diet and Cancer 1 |
| Cellular and Molecular Biology 42: Apoptosis Regulators 3 |
| Cellular and Molecular Biology 43: DNA Damage and Repair 2 |
| Cellular and Molecular Biology 44: Molecular Classification of Tumors 3 |
| Cellular and Molecular Biology 45: Molecular Genetics 4: Reproductive Cancers |
| Cellular and Molecular Biology 46: Molecular Genetics 5: Brain and Respiratory Cancers |
| Cellular and Molecular Biology 47: p53 Tumor Suppression |
| Cellular and Molecular Biology 48: Signaling in Breast Cancer 1 |
| Cellular and Molecular Biology 49: Signaling in Breast Cancer 2 |
| Cellular and Molecular Biology 50: Transcription Factors and Gene Regulation in Cancer |
| Tumor Biology 24: Extracellular Matrix and Cell Adhesion |
| Tumor Biology 25: In Vivo Imaging Using Magnetic Resonance and Computerized Tomography |
| Tumor Biology 26: In Vivo Imaging Using Radionuclide Probes: New Imaging Agents |
| Tumor Biology 27: Optical Imaging in Animal Models of Cancer |
| Tumor Biology 28: VEGF/VEGF Receptors |
| Carcinogenesis 6: Animal, In Vitro, and Other Models of Carcinogenesis |
| Carcinogenesis 7: Tumor Promotion and Signaling |
| Chemistry 8: Drug Design, Synthesis, and Screening |
| Clinical Research 13: Clinical Pharmacology of New Agents |
| Clinical Research 14: Molecular Markers in Diagnosis and Prognosis 4: Lung Cancer |
| Endocrinology 3: Endocrine-related Cancers and Agents |
| Epidemiology 9: Descriptive Epidemiology and Methodology |
| Epidemiology 10: DNA Repair Polymorphisms and Cancer Risk |
| Experimental and Molecular Therapeutics 33: Cellular and Molecular Pharmacology |
| Experimental and Molecular Therapeutics 34: Pharmacogenomics and Pharmacogenetics |
| Experimental and Molecular Therapeutics 35: Preclinical Pharmacology of New Agents |
| Experimental and Molecular Therapeutics 36: Preclinical Toxicology of New Agents / Outcomes Research |
| Experimental and Molecular Therapeutics 37: Prognostic and Predictive Markers |
| Immunology 7: Dendritic Cell-based Immunotherapy |
| Immunology 8: Humoral and Cellular Therapy |
| Prevention Research 9: Prevention of Breast, Prostate, and Skin Cancer |
| Cellular and Molecular Biology 51: Receptor Tyrosine Kinases in Cancer |
| Cellular and Molecular Biology 52: Telomeres and Telomerases in Cancer |
| Tumor Biology 29: Pediatric Cancer 2 |
| Tumor Biology 30: Proteolytic Systems and Tumor Progression |
| Chemistry 9: Proteome Profiling in Cancer Detection and Therapeutics |
| Endocrinology 4: Comparative Mechanisms of Hormone Resistance and Signaling in Breast and Prostate Cancer |
| Epidemiology 11: Inflammation and Immune Response in Cancer Risk |
| Experimental and Molecular Therapeutics 38: Death Pathways, DNA Repair, and Drug Delivery |
| Prevention Research 10: Targets for Cancer Prevention: Clinical and Preclinical Studies |
| Cellular and Molecular Biology 53: Cell Cycle Control and Cancer 1 |
| Cellular and Molecular Biology 54: DNA Repair in Human Cancers |
| Cellular and Molecular Biology 55: Molecular Classification of Tumors 4 |
| Cellular and Molecular Biology 56: Receptor-mediated Signaling |
| Cellular and Molecular Biology 56: Receptormediated Signaling |
| Cellular and Molecular Biology 57: Regulation of Transcription Factors and Gene Expression |
| Cellular and Molecular Biology 58: Signaling in Cancer |
| Cellular and Molecular Biology 59: Signaling in Hematological and Neural Cancers |
| Cellular and Molecular Biology 60: Transcriptional Control in Tumor Cells |
| Tumor Biology 31: Angiogenesis and Metastasis |
| Tumor Biology 32: Angiogenic Pathways |
| Tumor Biology 33: Inflammatory Cells and Molecules |
| Tumor Biology 34: Pediatric Cancer 3 |
| Tumor Biology 35: Radiation Biology 3 |
| Carcinogenesis 8: UV and Reactive Oxygen Species |
| Chemistry 10: Serum Proteome Profiling |
| Chemistry 11: Structural Biology |
| Clinical Research 15: Molecular Markers in Diagnosis and Prognosis 5: Barrett[rsquo ]s, Esophageal, Head and Neck, Leukemia, Lymphoma, and Brain |
| Clinical Research 16: Molecular Markers in Diagnosis and Prognosis 6: Gynecologic and Epithelial Cancers |
| Epidemiology 12: Polymorphisms Related to Inflammation, Immune Response, and Oxidative Damage |
| Experimental and Molecular Therapeutics 39: Biochemical Modulators and Combination Chemotherapy |
| Experimental and Molecular Therapeutics 40: Cellular Responses to Anticancer Agents 1 |
| Experimental and Molecular Therapeutics 41: Combination Chemotherapy and Chemosensitization |
| EXPERIMENTAL AND MOLECULAR THERAPEUTICS 41: Combination Chemotherapy and Chemosensitization |
| Experimental and Molecular Therapeutics 42: Cytokines, Oncogenes, and Other Gene Products as Targets for Therapy |
| EXPERIMENTAL AND MOLECULAR THERAPEUTICS 42: Cytokines, Oncogenes, and Other Gene Products as Targets for Therapy |
| Experimental and Molecular Therapeutics 43: Growth Factor Receptors as Targets for Therapy |
| Experimental and Molecular Therapeutics 44: Novel Drug Resistance Model Systems |
| Experimental and Molecular Therapeutics 45: Retinoids, HDACs, Nucleosides, Natural Products, and PARPs |
| Immunology 9: Tumor Antigens |
| Immunology 10: Tumor Vaccines 2 |
| Prevention Research 11: Diet and Cancer 2 |
| Prevention Research 12: Molecular Targets for Cancer Prevention: Development of New Agents |
| Clinical Research 16A: Contemporary Ethical/Human Considerations in Cancer Research |
| Cellular and Molecular Biology 61: Epigenetic Mechanisms 2 |
| Cellular and Molecular Biology 62: Signaling Downstream of Cell Surface Receptors |
| Tumor Biology 36: Animal Models 5: Breast, Lung, and Gastrointestinal Tract |
| TUMOR BIOLOGY 37: In Vivo Imaging |
| Carcinogenesis 9: Molecular Carcinogenesis 1 |
| Experimental and Molecular Therapeutics 46: Challenges in Targeting Mutant Kinases |
| Experimental and Molecular Therapeutics 47: Recent Progress in Gene Therapy of Cancer |
| Immunology 11: Tumor-induced Immune Suppression and Escape |
| Cellular and Molecular Biology 63: Apoptosis 4: Chemotherapeutic Agents II |
| Cellular and Molecular Biology 64: Apoptosis 5: Death Receptors II |
| Cellular and Molecular Biology 65: Apoptosis Regulators 4 |
| Cellular and Molecular Biology 66: Cell Cycle Control and Cancer 2 |
| Cellular and Molecular Biology 67: Cell Cycle Control and Cancer 3 |
| Cellular and Molecular Biology 68: Gene Expression in Tumor Cells |
| Cellular and Molecular Biology 69: Signal Transduction 1 |
| Cellular and Molecular Biology 70: Signal Transduction 2 |
| Cellular and Molecular Biology 71: Signaling in Gastrointestinal Cancers |
| Cellular and Molecular Biology 72: Signaling to the Nucleus |
| Tumor Biology 38: Markers of Tumor Progression 1 |
| Tumor Biology 39: Markers of Tumor Progression 2 |
| Tumor Biology 40: Mechanisms of Invasion and Motility 2 |
| Tumor Biology 41: Model Systems |
| Tumor Biology 42: Radiation Biology 4 |
| Carcinogenesis 10: Molecular Carcinogenesis 2 |
| Clinical Research 17: Therapy and Biomarker Evaluations of Phase II Clinical Trials |
| Endocrinology 5: Breast Endocrine Agents and Modifiers |
| Epidemiology 13: Diet and One Carbon Metabolism |
| Epidemiology 14: Nutrition Epidemiology in Cancer |
| Experimental and Molecular Therapeutics 48: Antiangiogenesis and Antivascular Agents |
| Experimental and Molecular Therapeutics 49: Cellular Responses to Anticancer Agents 2 |
| Experimental and Molecular Therapeutics 50: Novel Agents 2 |
| Experimental and Molecular Therapeutics 51: Novel Assays and Models |
| Experimental and Molecular Therapeutics 52: Prediction of Drug Sensitivity and Resistance |
| Experimental and Molecular Therapeutics 53: Targeting Signaling Pathways 2 |
| Immunology 12: Cytokines, Lymphokines, and Growth Factors |
| Immunology 13: Immunotherapy 2 |
| Immunology 14: Immunotherapy 3 |
| Prevention Research 13: Animal and Cellular Models for Prevention Studies |
| Cellular and Molecular Biology 73: Identifying New Tumor Suppressor Genes and Oncogenes |
| Cellular and Molecular Biology 74: RNA Interference, Small Interfering RNAs, and MicroRNAs: From Mechanism to Cancer Therapeutics |
| Cellular and Molecular Biology 75: Transcription Factors and Regulation of Gene Expression |
| Tumor Biology 43: Angiogenesis |
| Experimental and Molecular Therapeutics 54: Biologic Therapeutic Agents: Targets and Mechanisms |
| Experimental and Molecular Therapeutics 55: Modulation of Protein Stability |
| Experimental and Molecular Therapeutics 56: Pharmacogenomics, Pharmacokinetics, and Clinical Outcome |
| Immunology 15: Novel Vaccine and Antibody Approaches |
| Plenary Session: The Impact of Scientific Discovery on Cancer Diagnosis and Treatment |
| SYMPOSIUM 1: Advances in Cancer Immunotherapy |
| Symposium 3: Modeling the Complexities of Cancer in Vivo |
| Symposium 4: Molecular Imaging of Cancer: Pathways to Patients |
| Symposium 5: New Approaches to Targeting Receptor Tyrosine Kinases |
| Symposium 6: Transcription Factors as Targets for Chemoprevention |
| Symposium 7: Bio-Sensors and Signatures of the Angiogenic Tumor Vasculature: Tools for Early Detection and Monitoring Therapeutic Responses? |
| Symposium 8: G1/S Control and Its Deregulation in Cancer |
| Symposium 9: Genomic Instability and Cancer |
| Symposium 10: Inflammation and Cancer |
| Symposium 12: Role of the Tumor Microenvironment |
| Symposium 13: Drugs on the Horizon |
| Symposium 14: Estrogen Signaling and Cancer Development |
| Symposium 15: Genome Aberration Formation and Function |
| Symposium 16: Regulation of Cell Signaling by Ubiquitin Ligases |
| Symposium 17: Stem Cells and Cancer |
| Symposium 18: Using Functional Markers of DNA Repair in Epidemiological Studies |
| Symposium 19: AACR-Ruth Sager Symposium in Cancer Genetics and Epigenetics: Histone and DNA Modification: The Role of Altered Chromatin in Cancer |
| Symposium 20: Akt-mTOR Signaling in Cancer |
| Symposium 21: Beyond Apoptosis: Alternative Responses to Therapy in Tumor Cells |
| Symposium 22: Mutagenesis: The Chemical Agents and Chemical Mechanisms Underlying Genetic Change |
| Symposium 23: Regulation of Mitosis |
| Symposium 25: Advances in the Molecular Science of Cancer Prevention |
| Symposium 26: Aging and Cancer: Basic Biological Links |
| Symposium 27: Cancer Predisposition: Lessons Learned from Uncommon Developmental Disorders to Common Signaling Pathways |
| Symposium 28: Cellular Responses to Genotoxic Stress |
| Symposium 30: Targeting Apoptosis in Cancer |
| Symposium 31: ABC Transporters and Cancer Biology and Treatment |
| Symposium 32: Communicating Uncertain Risks, Benefits, and Controversies in Cancer Control |
| Symposium 33: Cross-Talk and Signaling Pathways in Tumor Progression and Metastasis |
| Symposium 34: Determinants of Metastasis |
| Symposium 35: DNA Repair Mechanisms |
